Appendix B to Subpart G to Part 1 - Headings for Information Items in § 1.823

(1) GENERAL INFORMATION:

(i) APPLICANT: (ii) TITLE OF INVENTION: (iii) NUMBER OF SEQUENCES: (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: (B) STREET: (C) CITY: (D) STATE: (E) COUNTRY: (F) ZIP: (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: (B) COMPUTER: (C) OPERATING SYSTEM: (D) SOFTWARE: (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: (B) FILING DATE: (C) CLASSIFICATION: (vii) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: (B) FILING DATE: (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: (B) REGISTRATION NUMBER: (C) REFERENCE/DOCKET NUMBER: (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: (B) TELEFAX: (C) TELEX:

(2) INFORMATION FOR SEQ ID NO: X:

(i) SEQUENCE CHARACTERISTICS: (A) LENGTH: (B) TYPE: (C) STRANDEDNESS: (D) TOPOLOGY: (ii) MOLECULE TYPE: —Genomic RNA; —Genomic DNA; —mRNA —tRNA; —rRNA; —snRNA; —scRNA; —preRNA; —cDNA to genomic RNA; —cDNA to mRNA; —cDNA to tRNA; —cDNA to rRNA; —cDNA to snRNA; —cDNA to scRNA; —Other nucleic acid;

(A) DESCRIPTION:

—protein and —peptide. (iii) HYPOTHETICAL: (iv) ANTI-SENSE: (v) FRAGMENT TYPE: (vi) ORIGINAL SOURCE: (A) ORGANISM: (B) STRAIN: (C) INDIVIDUAL ISOLATE: (D) DEVELOPMENTAL STAGE: (E) HAPLOTYPE: (F) TISSUE TYPE: (G) CELL TYPE: (H) CELL LINE: (I) ORGANELLE: (vii) IMMEDIATE SOURCE: (A) LIBRARY: (B) CLONE: (viii) POSITION IN GENOME: (A) CHROMOSOME/SEGMENT: (B) MAP POSITION: (C) UNITS: (ix) FEATURE: (A) NAME/KEY: (B) LOCATION: (C) IDENTIFICATION METHOD: (D) OTHER INFORMATION: (x) PUBLICATION INFORMATION: (A) AUTHORS: (B) TITLE: (C) JOURNAL: (D) VOLUME: (E) ISSUE: (F) PAGES: (G) DATE: (H) DOCUMENT NUMBER: (I) FILING DATE: (J) PUBLICATION DATE: (K) RELEVANT RESIDUES: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:X: